In a significant development for the Indian sports nutrition industry, MuscleBlaze (a brand under HealthKart) has been awarded a United States patent for its proprietary MB Enzyme Pro® (Proteolytic Enzyme Composition). The announcement, made by Sameer Maheshwari, CEO of HealthKart, coincides with the company’s 14th anniversary and marks an important milestone in whey protein formulation and digestion efficiency.
The MB Enzyme Pro® formulation, a core component of MuscleBlaze’s Biozyme Whey range, is designed to enhance protein digestibility and absorption. According to the company’s research, the enzyme blend increases postprandial amino acid levels by 50% compared to standard whey protein intake, potentially offering a more efficient protein delivery mechanism for athletes and fitness enthusiasts.
With this patent, MuscleBlaze claims to be the only brand globally to hold exclusive rights to this enzyme composition, setting it apart in the competitive whey protein industry.
MuscleBlaze has positioned itself as an innovator in the Indian sports nutrition market, introducing several industry-first initiatives. Some notable developments include:
According to HealthKart, the company has already filed over 25 patents across various nutrition categories, indicating a broader effort to protect its proprietary formulations and maintain a competitive edge.
In his LinkedIn post, Sameer Maheshwari acknowledged the significance of this patent, stating:
“This journey has been about pushing boundaries and ensuring Indian consumers receive the highest quality sports nutrition. We remain committed to scientific research and innovation, which is reflected in this achievement.”
He also credited Anupam Trehan and the R&D team for their role in securing the patent.
The US patent approval is likely to boost MuscleBlaze’s credibility in the global sports nutrition market. It also signals a shift in how Indian dairy-based nutrition products are perceived internationally. The emphasis on scientific research and intellectual property protection could set a precedent for other Indian dairy and sports nutrition companies looking to compete with established global brands.
With a patent-protected enzyme blend and an expanding portfolio, MuscleBlaze is expected to further leverage this innovation in new product formulations. The effectiveness and real-world impact of MB Enzyme Pro® on protein digestion and performance will likely be areas of interest for nutrition experts, competitive athletes, and regulatory bodies in the coming years.
